Oct 4 |
Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m
|
Oct 4 |
National Bank on DRI Healthcare's Casgevy Stream Acquisition
|
Oct 4 |
Editas trades Vertex fees for upfront cash in DRI deal
|
Oct 4 |
DRI Healthcare Trust Buying Payment Streams Based On Gene-Editing Technology For US$57 Million
|
Oct 4 |
Editas Medicine gets over $50M financing with DRI Healthcare Trust
|
Oct 3 |
Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust
|
Oct 1 |
Editas Medicine, Inc. (EDIT) Chardan's 8th Annual Genetic Medicines Conference (Transcript)
|
Sep 25 |
Editas Medicine: A Risk/Reward Worth Considering
|
Sep 17 |
Editas Medicine, Inc. (EDIT) 2024 Cantor Global Healthcare Conference (Transcript)
|
Sep 17 |
Where Editas Medicine Stands With Analysts
|